Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesWomens ImagingKaiser score outperforms MRI BI-RADS for inconclusive breast findingsKaiser scoring led to higher diagnostic accuracy on breast MRI.Molecular ImagingFAPI-PET detects more HCC lesions than FDG-PETHomeLLMs mostly avoid unnecessary care in Choosing Wisely testsNuclear MedicineEANM: Thomas Hope on what’s next in FAP-targeted theranosticsCardiac ImagingMRI shows no ties between COVID, future heart inflammation
![Comparative PET/CT scan images showing [18F]FAPI and [18F]FDG imaging with MIP projections, fusion views, and CT cross-sections for medical diagnosis](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/10/fapi-vs-fdg.nL6Acp6W2i.jpg?auto=format%2Ccompress&fit=crop&h=167&q=70&w=250)
